They found that the total RNA derived from CD40- B cells under the electroporation in cancer cells can also act as an alternative to APC for inducing antigen-particular CD8 + T cell responses, and these cells can therefore be employed for HCC immunotherapy. Here, CD8A is linked to hepatocellular carcinoma.